Yesterday afternoon the DT published an important report under the title “‘SpiDex’ – the drug cocktail that could defeat the new Covid variant” (paywalled link). That title certainly made me sit up, not least because of that label ‘Spidex’.  Turns out it’s no scary new drug, still to be investigated on human guinea pigs, as the subtitle explains: “Scientists offer hope after trials show a combination of spironolactone and dexamethasone work far better than dexamethasone alone”. This article deserves to be quoted extensively so we have a record. It might well be that this report could somehow be ‘vanished’ without trace.

First, here’s the historical background to this trial:

“Sir Christopher Edwards, the former vice-chancellor of Newcastle University, has recently conducted trials showing that a combination of spironolactone, a heart failure drug, and the steroid dexamethasone work far better than dexamethasone alone. Dexamethasone became the first drug to be licensed for the treatment of Covid-19 after Sir Christopher recommended the treatment to Sir John Bell, regius professor of medicine at Oxford University, who was tasked with finding drugs which could be repurposed for coronavirus. But he believes more lives could be saved if spironolactone was included, and is calling for wider trials of the “SpiDex” regime after early trials showed extremely promising results.” (paywalled link)

Next, the results – note that this trial was properly set up and run:

“In a randomised controlled trial in Delhi, just 5.4 per cent of hospitilised patients taking “SpiDex” needed to be admitted to intensive care compared to 19.6 per cent of those taking dexamethasone alone. A study published last week in Frontiers in Endocrinology also showed that 40 Covid-19 patients taking the “SpiDex” cocktail did better on every clinical, biochemical and radiological measure than 40 patients on a high dose of dexamethasone. No patients died while taking “SpiDex” but there was one death in the dexamethasone-only group. In 20 out-patients treated with “SpiDex” there were no adverse events, and 95 per cent were asymptomatic at 10 days including full recovery of taste and smell.” (paywalled link)

Why were these trials undertaken in India? Why not here in the UK? Were Indian doctors and Indian hospitals less scared of the WHO, of Fauci, of Big Pharma? The reason why this study might be binned a.s.a.p.? It’s clearly undermining the global “panic – omigawd omicron – more jabs now!” narrative. 

Here’s the scientific rationale, the reason why this trail was set up:

“Rather than targeting the virus itself, the treatments work by turning off the devastating impact on the body, so it means the drug combination should work against the extremely mutated “Nu” variant which is alarming scientists.

Sir Christopher, an eminent endocrinologist, said: “All the variants of the coronavirus use the same taxi to get into the cell, namely the ACE2 receptor.

“The destruction of the taxi results in a specific series of biochemical consequences which produce the symptoms and complications. SpiDex’ treatment blocks the consequences and does not depend on how the virus gets into the taxi. It is thus likely to be effective regardless of mutations in the spike protein of the virus such as those found in the recently discovered Nu variant.” The drugs work by shutting down the reaction which allows the virus to escape from cells and infect other cells. It also stops the deadly clotting and fluid retention in the lungs which often leads to death in Covid-19.”(paywalled link)

Remember that this study was published in ‘Frontiers in Endocrinology’ last week. Weren’t the eminent journals like The Lancet, Nature, the British Medical Journal and the US Medical journals not interested? Was the reason that this result doesn’t fit the ‘all must be jabbed’ narrative? See for yourselves:

“The success of the drugs also give clues about why young and healthy people are largely immune from the devastating impact of Covid-19. Younger people have fewer receptors in the lining of the blood vessels meaning the virus cannot cause problems in the more dangerous parts of the body. 

Sir Christopher was so convinced the treatment would work that he recommended it to his daughter-in-law when she became seriously ill with Covid-19 and was struggling to breathe. She made a full recovery. “If we can reproduce on a larger scale what these early trials suggest, the benefits could be extraordinary,” added Sir Christopher.” (paywalled link)

The report concludes with another quote from Sir Christopher – a quote which demonstrates nicely why this trial wasn’t greeted with great fanfare in the ‘big’ journals, enver mind the MSM or the covid government. Sir Christopher said:

“We all hope Covid-19 is going to go away, but it’s not going away. Spironolactone and dexamethasone are cheap off-patent drugs that could be immediately available, especially for parts of the world that cannot afford expensive anti-viral drugs or antibodies. If you look at the number of cases we’ve got and what’s going on, I think we’ve all got to wake up. You’ve only got to have a variant, or vaccine resistance, and you’re back to square one. We have to act now.”

Happily, the scientific world may be finally starting to come around to his point of view.” (paywalled link)

No they won’t! Nor will we hear more of this treatment because It’s cheap, the drugs are widely available, and above all it’ll make jabs superfluous because it works against all newcomer ‘variants of concern’. Oh, and because it must be racist, having been done in India. 

Anyone who still thinks this is about ‘protecting the health of our nation’ and not about control and the destruction of our civil liberties deserves all this despicable government will throw at them. Have a nice 1st Advent Sunday …

 

Print Friendly, PDF & Email